Nagercoil Stone Clinic Profile
Key Indicators
- Authorised Capital ₹ 2.10 M
as on 29-07-2024
- Paid Up Capital ₹ 2.10 M
as on 29-07-2024
- Company Age 19 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.50 M
as on 29-07-2024
- Revenue -34.48%
(FY 2023)
- Profit -267.84%
(FY 2023)
- Ebitda -331.82%
(FY 2023)
- Net Worth -12.19%
(FY 2023)
- Total Assets -6.68%
(FY 2023)
About Nagercoil Stone Clinic
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.10 M and a paid-up capital of Rs 2.10 M.
The company has closed loans amounting to ₹1.50 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Chandrakasan Gauthaman, Jeyaharan Jeyaharan, Subbramonian Kannan, and Three other members serve as directors at the Company.
- CIN/LLPIN
U85110TN2005PTC057571
- Company No.
057571
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Sep 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Kanyakumar District, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Nagercoil Stone Clinic?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subbramonian Kannan  | Managing Director | 21-Sep-2005 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jeyaharan Jeyaharan | Director | 21-Sep-2005 | Current |
| Chandrakasan Gauthaman | Director | 21-Sep-2005 | Current |
| Mohamed Hussain | Director | 21-Sep-2005 | Current |
| Nagamoni Kannan | Director | 21-Sep-2005 | Current |
| Sam Daniel | Director | 21-Sep-2005 | Current |
Financial Performance of Nagercoil Stone Clinic.
Nagercoil Stone Clinic Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 34.48% decrease. The company also saw a substantial fall in profitability, with a 267.84% decrease in profit. The company's net worth observed a substantial decline by a decrease of 12.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nagercoil Stone Clinic?
In 2023, Nagercoil Stone Clinic had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nagercoil Diagnostics Private LimitedActive 12 years 11 monthsChandrakasan Gauthaman and Jeyaharan Jeyaharan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 30 Mar 2006 | ₹1.50 M | Satisfied |
How Many Employees Work at Nagercoil Stone Clinic?
Unlock and access historical data on people associated with Nagercoil Stone Clinic, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nagercoil Stone Clinic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nagercoil Stone Clinic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
